Former Air Corps personnel say they were exposed to hazardous chemicals without protection, and feel the State has not ...
Neoadjuvant pembrolizumab (3 doses) in stage I–III disease yielded a 71% pCR rate and only one melanoma-specific survival event at 3 years post-resection. Experts discuss the SWOG S1512 trial of ...
Pew Research Center is a nonpartisan, nonadvocacy fact tank that informs the public about the issues, attitudes and trends shaping the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results